Donate Become an Insider

Home Shows Events Movies The People's Study Archive Get Alerts Contact Us

Children's Health Defense^® is a 501(c)(3) non-profit organization. Our mission is ending childhood health epidemics by eliminating toxic exposure. We will restore and protect the health of children by eliminating environmental exposures, holding responsible parties accountable, and establishing safeguards to prevent future harm of children's health. Protecting Children. Exposing Harms. Seeking Justice.

Take Action

Donate Join Our List Become an Insider

Donations are tax deductible to the full extent of the law. EIN #26-0388604

•Children's Health Defense
•Legal Disclaimer
•Terms of Use
•Privacy Policy
•Donate
•Work for CHD
•Contact
•Social

© 2016 - 2026 Children's Health Defense^® • All Rights Reserved

Mar 12, 2026

Mar 12, 2026

chat

FDA VRBPAC Meeting: Influenza Vaccines for 2026-2027

*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.

DonateJoin Our List

Resources

Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Briefing Document- FDA

Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Draft Roster

Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Presentation- Candidate Vaccine Strains and Potency Reagents: 2026-27 Northern Hemisphere Influenza Season

Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Presentation- Department of War Influenza Surveillance and Mid-Season Vaccine Effectiveness

Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Presentation- Global Influenza Virus Surveillance and Characterization- CDC

Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Presentation- Influenza Virus Vaccine Strain Selection 2026-2027 Influenza Season in the U.S

Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Presentation- Perspective: 2025-2026 and upcoming 2026-2027 Northern Hemisphere Influenza Seasons- Industry

Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Voting Questions

Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Waivers for Conflicts of Interest

chat

Agenda (in Eastern Time):

9:00 — Opening Remarks: Call to Order and Welcome
9:10 — Administrative Announcements, Roll Call, Introduction of Committee, Conflict of Interest Statement
9:30 — Open Public Hearing
10:30 — Introduction
10:45 — U.S. Influenza Surveillance and Preliminary Vaccine Effectiveness Estimates, 2025-26 Season
11:10 — Break
11:20 — Global Influenza Virus Surveillance and Characterization
12:30 — Break
1:00 — Department of War Influenza Surveillance and Mid-Season Vaccine Effectiveness
1:25 — Candidate Vaccine Strains & Potency Reagents
1:45 — Comments from Manufacturer Representative
2:10 — Committee Discussion, Recommendations, and Vote
3:30 — Closing Remarks and Adjournment

Related Videos

FDA VRBPAC Meeting | Oct. 9, 2025

FDA VRBPAC Meeting | Oct. 9, 2025

FDA VRBPAC Meeting | Influenza Vaccines, Avian Flu + Research Program Updates | Oct. 10

FDA VRBPAC Meeting | Influenza Vaccines, Avian Flu + Research Program Updates | Oct. 10

FDA VRBPAC Meeting | COVID-19 Vaccine Formulation for the 2025-2026 Season

FDA VRBPAC Meeting | COVID-19 Vaccine Formulation for the 2025-2026 Season

FDA VRBPAC Meeting: Moderna mRNA Influenza Vaccine Review

FDA VRBPAC Meeting: Moderna mRNA Influenza Vaccine Review

Login